Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure.

Rada M Vučić Olivera M AndrejicDragana StokanovicTatjana Jevtovic StoimenovLana McClementsValentina N NikolicMiodrag SreckovicMirjana VeselinovicSrdjan B Aleksandric Višeslav Popadić Marija ZdravkovićMilan Pavlovic

Published in: Diagnostics (Basel, Switzerland) (2023)

the Gal-3 plasma concentration in patients with AMI determined during coronary angiography, especially from the aortic root, within 24 h after chest pain onset is a valuable biomarker of prognosis at six months follow-up.

Keyphrases

acute myocardial infarction
left ventricular
heart failure
percutaneous coronary intervention
aortic valve
cardiac resynchronization therapy
atrial fibrillation
pulmonary hypertension
aortic dissection